| BVS Stock | | | USD 11.71 0.20 1.74% |
VP
Anthony DAdamio is General VP of Bioventus
| Age | 63 |
| Address | 4721 Emperor Boulevard, Durham, NC, United States, 27703 |
| Phone | 919 474 6700 |
| Web | https://www.bioventus.com |
Bioventus Management Efficiency
The company has Return on Asset of
0.0248 % which means that on every $100 spent on assets, it made $0.0248 of profit. This is way below average. In the same way, it shows a return on shareholders' equity
(ROE) of
(0.2476) %, meaning that it generated no profit with money invested by stockholders. Bioventus' management efficiency ratios could be used to measure how well Bioventus manages its routine affairs as well as how well it operates its assets and liabilities.
Return On Tangible Assets is likely to gain to -0.46 in 2024.
Return On Capital Employed is likely to gain to -0.12 in 2024. At this time, Bioventus'
Non Current Assets Total are comparatively stable compared to the past year.
Non Currrent Assets Other is likely to gain to about 3.3
M in 2024, whereas
Total Current Assets are likely to drop slightly above 212
M in 2024.
Bioventus has 394.85
M in debt with debt to equity
(D/E) ratio of 1.17, which is OK given its current industry classification. Bioventus has a current ratio of 0.92, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Bioventus to invest in growth at high rates of return.
Similar Executives
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the bodys natural healing process in the United States and internationally. The company was founded in 2011 and is headquartered in Durham, North Carolina. Bioventus Inc operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1160 people. Bioventus (BVS) is traded on NASDAQ Exchange in USA. It is located in 4721 Emperor Boulevard, Durham, NC, United States, 27703 and employs 1,030 people. Bioventus is listed under Health Care Equipment & Supplies category by Fama And French industry classification.
Management Performance
Bioventus Leadership Team
Elected by the shareholders, the Bioventus' board of directors comprises two types of representatives: Bioventus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bioventus. The board's role is to monitor Bioventus' management team and ensure that shareholders' interests are well served. Bioventus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bioventus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kenneth Reali, CEO Director | |
| MBA BS, Senior Operations | |
| Mark Singleton, Senior CFO | |
| Helen Leupold, Senior Officer | |
| Katrina Church, VP Officer | |
| Alessandraa Pavesio, VP Officer | |
| Anthony JD, General VP | |
| Larry Chen, Managing Pacific | |
| Anthony James, VP Quality | |
| Anthony DAdamio, General VP | |
| Robert Claypoole, CEO President | |
| David Crawford, Vice Treasurer | |
| Miguel BeltranDelgado, VP Operations | |
| Katrina JD, Senior Officer | |
| Jeff Welch, VP Devel | |
| Christopher Yamamoto, Sr Strategy | |
Bioventus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bioventus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Bioventus Stock Analysis
When running Bioventus' price analysis, check to
measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to
predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.